2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$38.85+$0.23 (+0.59%)
Price as of Aug 03, 2026 7:18 AM EDT- $7.9BMarket Cap
- 145.83%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$38.85+$0.23 (+0.59%)
Earnings Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 41.31% | ||
12-Month Momentum | 137.19% | ||
3-Month Risk Adjusted Momentum | 103.26% | ||
12-Month Risk Adjusted Momentum | 225.07% |
True Yield
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | IMVT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -1 |